CTIX has a high probability of coming in this next year. May even get a pr that moves us first part of December.

The FDA protocols can almost be used as a calender. As specific points in the trial are hit the company will have data to pr. That's where first part of December comes in.

It's only a dollar at last close. Following are links of interest. Do your own DD. I'm just helping you get started.

CTIX articles:

Cellceutix CEO Leo Ehrlich Interviewed by TheStreetBeat.com
Leo Interview April 2012
http://www.zimbio.com/Dana-Farber+Cancer+Inst...StreetBeat

~~~~~~~~~~

analyst view
MAY 4, 2011

http://www.thegreenbaron.com/Cellceutix%20Ana...Format.pdf

or https://docs.google.com/viewer?a=v&q=cach...cWwqfyGefQ

~~~~~~~~~~

Pfizer Eyes Kevetrin?
August 13, 2012

http://seekingalpha.com/article/802771-pfizer-eyes-kevetrin

~~~~~~~~~~

Rodman and Renshaw part 1 and 2
September 11, 2012
http://cellceutix.com/events/

~~~~~~~~~~

Cellceutix Clinical Trials at Dana Farber and Beth Israel Deaconess Now Active
October 22, 2012
http://www.zimbio.com/Dana-Farber+Cancer+Inst...arber+Beth

~~~~~~~~~~

My Stock of the Year for 2013: Cellceutix Corporation (CTIX)
November 8, 2012 PUBLISHED IN: Market Analysis
http://www.allantrends.com/my-stock-of-the-ye...tion-ctix/

~~~~~~~~~~

BioTuesdays Says Cellceutix Better than Competition
November 22, 2012
http://www.zimbio.com/Blogger+Tips+and+Tricks...ompetition

General overview of dd
November 24, 2012
http://investorshangout.com/post/view?id=168277

~~~~~~~~~~

Kevetrin™ targets both MDM2-p53 and Rb-E2F pathways in tumor suppression
http://cellceutix.com/wp-content/uploads/pdfs...0FINAL.pdf

~~~~~~~~~~

FDA site listing protocols:

http://www.clinicaltrials.gov/ct2/show/NCT016...amp;rank=1

Phase one data points simplified: http://investorshangout.com/post/view?id=163713